Testing the usefulness of Lantus [insulin glargine] when initiated prematurely in patients with type 2 diabetes.

Trial Profile

Testing the usefulness of Lantus [insulin glargine] when initiated prematurely in patients with type 2 diabetes.

Completed
Phase of Trial: Phase IV

Latest Information Update: 23 Feb 2010

At a glance

  • Drugs Insulin glargine (Primary)
  • Indications Type 2 diabetes mellitus
  • Focus Therapeutic Use
  • Acronyms TULIP
  • Most Recent Events

    • 01 Apr 2009 Primary endpoints 'Glycaemic response rate' and 'target achievement rate' have been met according to results published in Diabetes, Obesity and Metabolism.
    • 05 Jul 2007 Status changed from in progress to completed.
    • 11 Aug 2006 Status change
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top